Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Project Q: D-cycloserine for Smoking Cessation in Light Smokers
NCT03416621Phase 3Completed
- Sponsor
- Duke University
- Start
- May 2018
- Primary completion
- Feb 2020
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of d-cycloserine in Tobacco Use Disorder (TUD), sponsored by Duke University. Started May 2018; status: completed.
02
Drugs
d-cycloserine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03416621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03416621.